Wider D - Search Results

Year	Number of Results
1996	1
2006	1
2007	1
2009	1
2010	1
2011	1
2012	1
2013	2
2015	2
2016	2
2017	3
2018	2
2019	1
2020	2
2021	1
2022	2
2023	1
2024	1

1

Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life.

Bhattacharya K, Maiti S, Zahoran S, Weidenauer L, Hany D, Wider D, Bernasconi L, Quadroni M, Collart M, Picard D. Bhattacharya K, et al. Among authors: wider d. Nat Commun. 2022 Oct 21;13(1):6271. doi: 10.1038/s41467-022-33916-3. Nat Commun. 2022. PMID: 36270993 Free PMC article.

2

Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma.

Waldschmidt JM, Fruttiger SJ, Wider D, Jung J, Thomsen AR, Hartmann TN, Duyster J, Hug MJ, Azab KA, Jung M, Wäsch R, Engelhardt M. Waldschmidt JM, et al. Among authors: wider d. J Cancer Res Clin Oncol. 2022 May;148(5):1045-1055. doi: 10.1007/s00432-021-03854-6. Epub 2022 Jan 24. J Cancer Res Clin Oncol. 2022. PMID: 35072775 Free PMC article.

3

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

Bhattacharya K, Weidenauer L, Luengo TM, Pieters EC, Echeverría PC, Bernasconi L, Wider D, Sadian Y, Koopman MB, Villemin M, Bauer C, Rüdiger SGD, Quadroni M, Picard D. Bhattacharya K, et al. Among authors: wider d. Nat Commun. 2020 Nov 25;11(1):5975. doi: 10.1038/s41467-020-19783-w. Nat Commun. 2020. PMID: 33239621 Free PMC article.

4

Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma.

Dold SM, Riebl V, Wider D, Follo M, Pantic M, Ihorst G, Duyster J, Zeiser R, Wäsch R, Engelhardt M. Dold SM, et al. Among authors: wider d. Haematologica. 2020 Oct 1;105(10):e523. doi: 10.3324/haematol.2019.238394. Haematologica. 2020. PMID: 33054097 Free PMC article. No abstract available.

5

Hsf1 and the molecular chaperone Hsp90 support a 'rewiring stress response' leading to an adaptive cell size increase in chronic stress.

Maiti S, Bhattacharya K, Wider D, Hany D, Panasenko O, Bernasconi L, Hulo N, Picard D. Maiti S, et al. Among authors: wider d. Elife. 2023 Dec 7;12:RP88658. doi: 10.7554/eLife.88658. Elife. 2023. PMID: 38059913 Free PMC article.

6

APC/C^Cdh1 regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells.

Ewerth D, Kreutmair S, Schmidts A, Ihorst G, Follo M, Wider D, Felthaus J, Schüler J, Duyster J, Illert AL, Engelhardt M, Wäsch R. Ewerth D, et al. Among authors: wider d. Cell Mol Life Sci. 2019 Jan;76(2):369-380. doi: 10.1007/s00018-018-2952-3. Epub 2018 Oct 24. Cell Mol Life Sci. 2019. PMID: 30357422

7

A regionally based precision medicine implementation initiative in North Africa:The PerMediNA consortium.

Hamdi Y, Boujemaa M, Ben Aissa-Haj J, Radouani F, Khyatti M, Mighri N, Hannachi M, Ghedira K, Souiai O, Hkimi C, Kammoun MS, Mejri N, Bouaziz H, Beloufa MA, Charoute H, Barakat A, Najjar I, Taniguchi H, Pietrosemoli N; PerMediNA Consortium; Dellagi K, Abdelhak S, Boubaker MS, Chica C, Rouleau E. Hamdi Y, et al. Transl Oncol. 2024 Jun;44:101940. doi: 10.1016/j.tranon.2024.101940. Epub 2024 Mar 26. Transl Oncol. 2024. PMID: 38537326 Free article.

8

Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma).

Waldschmidt JM, Keller A, Ihorst G, Grishina O, Müller S, Wider D, Frey AV, King K, Simon R, May A, Tassone P, Duyster J, Jung M, Raje N, Wäsch R, Engelhardt M. Waldschmidt JM, et al. Among authors: wider d. Haematologica. 2018 Oct;103(10):e473-e479. doi: 10.3324/haematol.2018.189969. Epub 2018 Apr 19. Haematologica. 2018. PMID: 29674494 Free PMC article. Clinical Trial. No abstract available.

9

Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients.

Riebl V, Dold SM, Wider D, Follo M, Ihorst G, Waldschmidt JM, Jung J, Rassner M, Greil C, Wäsch R, Engelhardt M. Riebl V, et al. Among authors: wider d. Front Oncol. 2021 Aug 13;11:708231. doi: 10.3389/fonc.2021.708231. eCollection 2021. Front Oncol. 2021. PMID: 34485145 Free PMC article.

10

From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration.

Lorenz J, Waldschmidt J, Wider D, Follo M, Ihorst G, Chatterjee M, May AM, Duyster J, Rosenwald A, Wäsch R, Zirlik K, Engelhardt M. Lorenz J, et al. Among authors: wider d. Br J Haematol. 2016 Sep;174(6):985-9. doi: 10.1111/bjh.13825. Epub 2015 Oct 22. Br J Haematol. 2016. PMID: 26491948 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year